Indo Us Bio-Tech Balance Sheet Health
Financial Health criteria checks 5/6
Indo Us Bio-Tech has a total shareholder equity of ₹545.0M and total debt of ₹116.0M, which brings its debt-to-equity ratio to 21.3%. Its total assets and total liabilities are ₹694.7M and ₹149.7M respectively. Indo Us Bio-Tech's EBIT is ₹122.3M making its interest coverage ratio 9. It has cash and short-term investments of ₹1.9M.
Key information
21.3%
Debt to equity ratio
₹115.99m
Debt
Interest coverage ratio | 9x |
Cash | ₹1.90m |
Equity | ₹544.96m |
Total liabilities | ₹149.69m |
Total assets | ₹694.65m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 541304's short term assets (₹599.1M) exceed its short term liabilities (₹122.9M).
Long Term Liabilities: 541304's short term assets (₹599.1M) exceed its long term liabilities (₹26.8M).
Debt to Equity History and Analysis
Debt Level: 541304's net debt to equity ratio (20.9%) is considered satisfactory.
Reducing Debt: 541304's debt to equity ratio has reduced from 87% to 21.3% over the past 5 years.
Debt Coverage: 541304's debt is not well covered by operating cash flow (4.5%).
Interest Coverage: 541304's interest payments on its debt are well covered by EBIT (9x coverage).